The GARFIELD-AF tool allows a single calculation for mortality, stroke and bleeding and can assist in risk/benefit decision-making.
The GARFIELD-AF(Global Anticoagulant Registry in the FIELD–Atrial Fibrillation) Risk Stratification Tool was derived from prospective data from the GARFIELD-AF registry of 52032 patients over 2 years. The aim was:
- To derive and validate a new risk model for predicting mortality, nonhaemorrhagic stroke/SE, and major bleeding up to 2 years after enrolment based on treatment selection.
- To include the feature of treatment selection in GARFIELD-AF risk calculator to assist clinicians in applying guideline adherence to anticoagulation decisions for patients with AF
What They did
Comparisons of the performance of the new GARFIELD-AF risk models were made with the CHA2DS2-VASc score and HAS-BLED score. The validity of the risk models was tested externally in patients with AF from an independent US-based registry, the ORBIT-AF registry and Danish nationwide registries.
This content is locked
Login To Unlock The Content!
